Substance
BLINATUMOMAB
Global reference: every product and company linked to this substance.
- cas: 853426-35-4
- ncit: C62528
- rxnorm: 1597258
- unii: 4FR53SIF3A
AMG-103 · AMG103 · blinatumomab [INN] · BLINATUMOMAB [JAN] · BLINATUMOMAB [USAN] · Blinatumomab [WHO-DD] · BLINCYTO · MEDI-538 · MEDI538 · MT-103 · MT103
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| AMGEN INC. COMMON STOCK | BLINCYTO | Q2 2026 | $472.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- BLINCYTO · AMGEN INC. COMMON STOCK